Trials / Completed
CompletedNCT01216579
Steroid Titration Against Mannitol IN Asthma
Titrating Inhaled Steroid Dose Against Mannitol Hyper-responsiveness or BTS Outcomes: Comparative Effects on Asthma Exacerbations Over 1 Year
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- University of Dundee · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesise that titration of asthma medication against mannitol challenge results will reduce the number of mild asthma exacerbations, in one year, when compared with titration against BTS guidelines. To test this hypothesis the investigators propose a primary care, parallel treatment, patient blinded study in which matched groups of asthmatic patients will be treated in accordance either with BTS guidelines or with our treatment algorithm dependent on mannitol challenge result. Purpose of the study is to evaluate the efficacy of a treatment algorithm based on the measurement of airway hyperresponsiveness to mannitol challenge, a surrogate marker of airway inflammation, in the long term treatment of asthma in comparison to BTS guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mannitol (an airway challenge agent) |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2010-02-01
- First posted
- 2010-10-07
- Last updated
- 2010-10-07
Source: ClinicalTrials.gov record NCT01216579. Inclusion in this directory is not an endorsement.